Drug regulator grants emergency use approval to anti-Covid drug developed jointly by DRDO and Dr Reddy’s
2021-05-08
Share List Nirbhay Kumar New Delhi: Indian drug regulator DCGI has approved an anti-Covid drug (2-DG) jointly developed by Defence Research and Development Organisation (DRDO) and home-grown pharma major Dr Reddy’s Laboratories for emergency use. The new drug would come in powder form in sachet and can be taken orallyContinue Reading